[1]
|
Alsharhan, L. and Beck, L.J. (2021) Membranous Nephropathy: Core Curriculum 2021. American Journal of Kidney Diseases, 77, 440-453. https://doi.org/10.1053/j.ajkd.2020.10.009
|
[2]
|
Liu, W., Gao, C., Liu, Z., Dai, H., Feng, Z., Dong, Z., et al. (2020) Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity. Frontiers in Immunology, 11, Article No. 1846.
https://doi.org/10.3389/fimmu.2020.01846
|
[3]
|
Keri, K.C., Blumenthal, S., Kulkarni, V., Beck, L. and Chongkrairatanakul, T. (2019) Primary Membranous Nephropathy: Comprehensive Review and Historical Perspective. Postgraduate Medical Journal, 95, 23-31.
https://doi.org/10.1136/postgradmedj-2018-135729
|
[4]
|
McAdoo, S.P. and Pusey, C.D. (2017) Anti-Glomerular Basement Membrane Disease. Clinical Journal of the American Society of Nephrology, 12, 1162-1172. https://doi.org/10.2215/CJN.01380217
|
[5]
|
Pedchenko, V., Kitching, A.R. and Hudson, B.G. (2018) Goodpas-ture’s Autoimmune Disease—A Collagen IV Disorder. Matrix Biology, 71-72, 240-249. https://doi.org/10.1016/j.matbio.2018.05.004
|
[6]
|
Segelmark, M. and Hellmark, T. (2019) Anti-Glomerular Base-ment Membrane Disease: An Update on Subgroups, Pathogenesis and Therapies. Nephrology Dialysis Transplantation, 34, 1826-1832. https://doi.org/10.1093/ndt/gfy327
|
[7]
|
Rodriguez, E.F., Nasr, S.H., Larsen, C.P., Sethi, S., Fidler, M.E. and Cornell, L.D. (2014) Membranous Nephropathy with Crescents: A Series of 19 Cases. American Journal of Kidney Diseases, 64, 66-73.
https://doi.org/10.1053/j.ajkd.2014.02.018
|
[8]
|
Troxell, M.L., Saxena, A.B. and Kambham, N. (2006) Concurrent Anti-Glomerular Basement Membrane Disease and Membranous Glomerulonephritis: A Case Report and Literature Re-view. Clinical Nephrology, 66, 120-127.
https://doi.org/10.5414/CNP66120
|
[9]
|
Speer, C., Gaida, M.M., Waldherr, R., Nusshag, C., Kälble, F. and Zeier, M. (2018) Membranous Nephropathy Followed by Anti-Glomerular Basement Disease: A Case Report and Review of Clinical Presentation and Treatment. SAGE Open Medical Case Reports, 6, Article ID: 2050313X18807621. https://doi.org/10.1177/2050313X18807621
|
[10]
|
Patel, D., Nivera, N. and Tunkel, A.R. (2010) Anti-Glomerular Basement Membrane Disease Superimposed on Membranous Nephropathy: A Case Report and Review of the Literature. Journal of Medical Case Reports, 4, Article No. 237. https://doi.org/10.1186/1752-1947-4-237
|
[11]
|
包红梅, 张建春, 陈晓明, 等. 膜性肾病合并肾功能轻度受损的抗肾小球基底膜病一例报道及文献复习[J]. 临床肾脏病杂志, 2017, 17(4): 221-225.
|
[12]
|
Kant, S., Kronbichler, A., Sharma, P. and Geetha, D. (2021) Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review. American Journal of Kidney Diseases, 79, 582-600.
|
[13]
|
Ronco, P. and Debiec, H. (2020) Molecular Pathogenesis of Membranous Nephropathy. Annual Review of Pathology: Mechanisms of Disease, 15, 287-313. https://doi.org/10.1146/annurev-pathol-020117-043811
|
[14]
|
Kurki, P., Helve, T., von Bonsdorff, M., Törnroth, T., Pettersson, E., Riska, H., et al. (1984) Transformation of Membranous Glomerulonephritis into Crescentic Glomerulo-nephritis with Glomerular Basement Membrane Antibodies. Serial Determinations of Anti-GBM before the Transfor-mation. Nephron, 38, 134-137.
https://doi.org/10.1159/000183294
|
[15]
|
Qu, Z., Cui, Z., Liu, G. and Zhao, Mi.-H. (2013) The Distribution of IgG Subclass Deposition on Renal Tissues from Patients with Anti-Glomerular Basement Membrane Disease. BMC Immu-nology, 14, Article No. 19.
https://doi.org/10.1186/1471-2172-14-19
|
[16]
|
Jia, X.Y., Hu, S.Y., Chen, J.L., Qu, Z., Liu, G., Cui, Z., et al. (2014) The Clinical and Immunological Features of Patients with Combined Anti-Glomerular Basement Membrane Dis-ease and Membranous Nephropathy. Kidney International, 85, 945-952. https://doi.org/10.1038/ki.2013.364
|
[17]
|
Hoshino, J., Hara, S., Ubara, Y., Takaya, H., Suwabe, T., Sawa, N., et al. (2005) Distribution of IgG Subclasses in a Biopsy Specimen Showing Membranous Nephropathy with Anti-Glomerular baseMent Membrane Glomerulonephritis: An Uncharacteristically Good Outcome with Corticosteroid Therapy. Ameri-can Journal of Kidney Diseases, 45, e67-e72. https://doi.org/10.1053/j.ajkd.2005.01.009
|
[18]
|
Pedchenko, V., Bondar, O., Fogo, A.B., Vanacore, R., Voziyan, P., Kitching, A.R., et al. (2010) Molecular Architecture of the Good-pasture Autoantigen in Anti-GBM Nephritis. New England Journal of Medicine, 363, 343-354.
https://doi.org/10.1056/NEJMoa0910500
|
[19]
|
Zhao, J., Cui, Z., Yang, R., Jia, X.Y., Zhang, Y. and Zhao, M.H. (2009) Anti-Glomerular Basement Membrane Autoantibodies against Different Target Antigens Are Associated with Disease Severity. Kidney International, 76, 1108- 1115. https://doi.org/10.1038/ki.2009.348
|
[20]
|
Rees, A.J., Pe-ters, D.K., Amos, N., Welsh, K.I. and Batchelor, J.R. (1984) The Influence of HLA-Linked Genes on the Severity of Anti-GBM Antibody-Mediated Nephritis. Kidney International, 26, 445-450.
https://doi.org/10.1038/ki.1984.194
|
[21]
|
Hiki, Y., Kobayashi, Y., Itoh, I. and Kashiwagi, N. (1984) Strong Asso-ciation of HLA-DR2 and MT1 with Idiopathic Membranous Nephropathy in Japan. Kidney International, 25, 953-967. https://doi.org/10.1038/ki.1984.116
|
[22]
|
Huang, C.C. (1989) Strong Association of HLA-DR3 in Chinese Patients with Idiopathic Membranous Nephropathy. Tissue Antigens, 33, 425-426. https://doi.org/10.1111/j.1399-0039.1989.tb01688.x
|
[23]
|
Elder, G., Perl, S., Yong, J.L., Fletcher, J. and Mackie, J. (1995) Progression from Goodpasture’s Disease to Membranous Glomerulonephritis. Pathology, 27, 233-236. https://doi.org/10.1080/00313029500169043
|
[24]
|
Kerjaschki, D. and Neale, T.J. (1996) Molecular Mechanisms of Glomerular Injury in Rat Experimental Membranous Nephropathy (Heymann nephritis). Journal of the American Society of Nephrology, 7, 2518-2526.
https://doi.org/10.1681/ASN.V7122518
|
[25]
|
陈文腾. 抗基底膜肾小球肾炎合并膜性肾病病例报告并文献复习[J]. 齐齐哈尔医学院学报, 2018, 39(14): 1627-1631.
|
[26]
|
Dwyer, D.S., Bradley, R.J., Urquhart, C.K. and Kearney, J.F. (1983) Naturally Occurring Anti-Idiotypic Antibodies in Myasthenia Gravis Patients. Nature, 301, 611-614. https://doi.org/10.1038/301611a0
|
[27]
|
Glassock, R.J. (2020) Membranous Nephropathy Due to Anti-GBM Anti-bodies of Mice and Men. American Journal of Nephrology, 51, 96-98. https://doi.org/10.1159/000505738
|
[28]
|
McAdoo, S.P. and Pusey, C.D. (2018) Antiglomerular Basement Mem-brane Disease. Seminars in Respiratory and Critical Care Medicine, 39, 494-503. https://doi.org/10.1055/s-0038-1669413
|
[29]
|
Ogawara, A., Harada, M., Ichikawa, T., Fujii, K., Ehara, T. and Ko-bayashi, M. (2017) Coexistence of Anti-Glomerular Basement Membrane Glomerulonephritis and Membranous Nephropathy in a Female Patient with Preserved Renal Function. The Tohoku Journal of Experimental Medicine, 243, 335-341. https://doi.org/10.1620/tjem.243.335
|
[30]
|
Nikolopoulou, A., Huang-Doran, I., McAdoo, S.P., Griffith, M.E., Cook, H.T. and Pusey, C.D. (2019) Membranous Glomerulonephritis with Crescents. Kidney International Re-ports, 4, 1577-1584.
https://doi.org/10.1016/j.ekir.2019.07.021
|
[31]
|
Nasr, S.H., Collins, A.B., Alexander, M.P., Schraith, D.F., Herrera Hernandez, L., Fidler, M.E., et al. (2016) The Clinicopathologic Characteristics and Outcome of Atypical An-ti-Glomerular Basement Membrane Nephritis. Kidney International, 89, 897-908. https://doi.org/10.1016/j.kint.2016.02.001
|
[32]
|
Rovin, B.H., Adler, S.G., Barratt, J., Bridoux, F., Burdge, K.A., Chan, T.M., et al. (2021) Executive Summary of the KDIGO 2021 Guideline for the Management of Glomerular Dis-eases. Kidney International, 100, 753-779.
https://doi.org/10.1016/j.kint.2021.05.015
|
[33]
|
Stummvoll, G., Aringer, M., Handisurya, A. and Derfler, K. (2017) Immunoadsorption in Autoimmune Diseases Affecting the Kidney. Seminars in Nephrology, 37, 478-487. https://doi.org/10.1016/j.semnephrol.2017.05.020
|
[34]
|
Shah, Y., Mohiuddin, A., Sluman, C., Daryanani, I., Led-son, T., Banerjee, A., et al. (2012) Rituximab in Anti-Glomerular Basement Membrane Disease. QJM, 105, 195-197. https://doi.org/10.1093/qjmed/hcr001
|
[35]
|
Santos, J.E., Fiel, D., Santos, R., Vicente, R., Aguiar, R., Santos, I., et al. (2020) Rituximab Use in Adult Glomerulopathies and Its Rationale. Brazilian Journal of Nephrology, 42, 77-93.
https://doi.org/10.1590/2175-8239-jbn-2018-0254
|
[36]
|
Bandak, G., Jones, B.A., Li, J., Yee, J. and Umanath, K. (2014) Rituximab for the Treatment of Refractory Simultaneous Anti-Glomerular Basement Membrane (Anti-GBM) and Membranous Nephropathy. Clinical Kidney Journal, 7, 53-56. https://doi.org/10.1093/ckj/sft152
|